Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report) gapped up prior to trading on Thursday . The stock had previously closed at $133.60, but opened at $143.4960. Pro Medicus shares last traded at $143.4960, with a volume of 328 shares traded.
Wall Street Analyst Weigh In
Separately, Jefferies Financial Group lowered shares of Pro Medicus from a “buy” rating to a “hold” rating in a research note on Wednesday, July 8th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $155.00.
Get Our Latest Research Report on PMCUF
Pro Medicus Price Performance
Pro Medicus Company Profile
Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
See Also
- Five stocks we like better than Pro Medicus
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
